Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)
Journal
-
- Annals of Oncology
-
Annals of Oncology 24 (4), 993-999, 2013-04
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360574094769986688
-
- ISSN
- 09237534
-
- Data Source
-
- Crossref